Literature DB >> 16785518

Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products.

Shu-Bing Qian1, Eric Reits, Jacques Neefjes, Jeanne M Deslich, Jack R Bennink, Jonathan W Yewdell.   

Abstract

There is mounting evidence that MHC class I peptide ligands are predominantly generated from defective ribosomal products and other classes of polypeptides degraded rapidly (t1/2 < 10 min) following their synthesis. The most direct evidence supporting this conclusion is the rapid inhibition of peptide ligand generation following cycloheximide-mediated inhibition of protein synthesis. In this study, we show that this linkage is due to depleting the pool of rapidly degraded proteins, and not to interference with other protein synthesis-dependent processes. Our findings indicate that in the model systems used in this study, MHC class I peptides are preferentially generated from rapidly degraded polypeptides relative to slowly degraded proteins. This conclusion is supported by the properties of peptide presentation from slowly degraded (t1/2 = 4 h) defective ribosomal products generated artificially by incorporation of the amino acid analog canavanine into a model viral Ag. We propose that specialized machinery exists to link protein synthesis with class I peptide ligand generation to enable the rapid detection of viral gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785518     DOI: 10.4049/jimmunol.177.1.227

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

Review 1.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

2.  Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action.

Authors:  Avital Lev; Michael F Princiotta; Damian Zanker; Kazuyo Takeda; James S Gibbs; Chiharu Kumagai; Elizabeth Waffarn; Brian P Dolan; Anne Burgevin; Peter Van Endert; Weisan Chen; Jack R Bennink; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

3.  The pathogenicity of self-antigen decreases at high levels of autoantigenicity: a computational approach.

Authors:  Anmar Khadra; Pere Santamaria; Leah Edelstein-Keshet
Journal:  Int Immunol       Date:  2010-05-24       Impact factor: 4.823

4.  mTORC1 links protein quality and quantity control by sensing chaperone availability.

Authors:  Shu-Bing Qian; Xingqian Zhang; Jun Sun; Jack R Bennink; Jonathan W Yewdell; Cam Patterson
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

5.  Substrate-induced protein stabilization reveals a predominant contribution from mature proteins to peptides presented on MHC class I.

Authors:  Jeff D Colbert; Diego J Farfán-Arribas; Kenneth L Rock
Journal:  J Immunol       Date:  2013-10-30       Impact factor: 5.422

6.  Hydrophobicity as a driver of MHC class I antigen processing.

Authors:  Lan Huang; Matthew C Kuhls; Laurence C Eisenlohr
Journal:  EMBO J       Date:  2011-03-04       Impact factor: 11.598

Review 7.  Re-examining class-I presentation and the DRiP hypothesis.

Authors:  Kenneth L Rock; Diego J Farfán-Arribas; Jeff D Colbert; Alfred L Goldberg
Journal:  Trends Immunol       Date:  2014-02-21       Impact factor: 16.687

8.  Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance.

Authors:  Brian P Dolan; Lily Li; Charles A Veltri; Chris M Ireland; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2011-01-12       Impact factor: 5.422

Review 9.  Modulation of the Translational Landscape During Herpesvirus Infection.

Authors:  Britt A Glaunsinger
Journal:  Annu Rev Virol       Date:  2015-07-02       Impact factor: 10.431

10.  T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display.

Authors:  Laura K Mackay; Heather M Long; Jill M Brooks; Graham S Taylor; Carol S Leung; Adrienne Chen; Fred Wang; Alan B Rickinson
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.